Testosterone hallucination by artificial intelligence? ENZAMET trial, in the Spring of 2023-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Testosterone hallucination by artificial intelligence? ENZAMET trial, in the Spring of 2023

Published:2024-04 Issue:2 Volume:7 Page:268-269
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:

Author:

Natchagande Gilles¹,Vinh-Hung Vincent²,Verschraegen Claire³

Affiliation:

1. Department of Urology, Regional University Hospital of Oueme-Plateau (CHUD/OP), Porto Novo, Republic of Benin

2. Department of Radiotherapy, Center Hospitalier Public du Cotentin, Cherbourg-en-Cotentin, France

3. Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA

Publisher

Medknow

Reference7 articles.

1. ChatGPT:Proceed with caution;Mathew;Cancer Res Stat Treat,2023

2. Authors'reply to Sathe et al., Cherulil et al., Vaishya et al., and Gupta et al;Parikh;Cancer Res Stat Treat,2023

3. Decoding ChatGPT's 'impact'on the future of healthcare;Pearce;Cancer Res Stat Treat,2023

4. Development of a second-generation antiandrogen for treatment of advanced prostate cancer;Tran;Science,2009

5. Enzalutamide with standard first-line therapy in metastatic prostate cancer;Davis;N Engl J Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP